The Couer d’Alene Resort in Idaho is the perfect place to get 14.75 hours of CME on August 13-14th. It’s less than 30 minutes from the Spokane airport. http://www.cdaresort.com/ This is the 4th year of the International Conference in Hematology … Continued
The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.